BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 11266874)

  • 1. Development of an oral formulation for ICAM-1 antisense oligonucleotides.
    Stepkowski SM; Chen W; Geary R; Wang ME; Condon T; Stecker K; Bennett CF
    Transplant Proc; 2001; 33(1-2):387. PubMed ID: 11266874
    [No Abstract]   [Full Text] [Related]  

  • 2. Antisense ICAM-1 oligonucleotides block allograft rejection in rats.
    Stepkowski SM; Wang ME; Amante A; Kalinin D; Qu X; Blasdel T; Condon T; Kahan BD; Bennett FC
    Transplant Proc; 1997; 29(1-2):1285. PubMed ID: 9123308
    [No Abstract]   [Full Text] [Related]  

  • 3. An oral formulation for intracellular adhesion molecules-1 antisense oligonucleotides.
    Stepkowski SM; Chen W; Geary R; Wang ME; Condon T; Stecker K; Bennett CF
    Transplant Proc; 2001; 33(7-8):3271. PubMed ID: 11750400
    [No Abstract]   [Full Text] [Related]  

  • 4. Methoxyethyl-modified intercellular adhesion molecule-1 antisense phosphorothiateoligonucleotides inhibit allograft rejection, ischemic-reperfusion injury, and cyclosporine-induced nephrotoxicity.
    Chen W; Langer RM; Janczewska S; Furian L; Geary R; Qu X; Wang M; Verani R; Condon T; Stecker K; Bennett CF; Stepkowski SM
    Transplantation; 2005 Feb; 79(4):401-8. PubMed ID: 15729165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection against allograft rejection with intercellular adhesion molecule-1 antisense oligodeoxynucleotides.
    Stepkowski SM; Wang ME; Condon TP; Cheng-Flournoy S; Stecker K; Graham M; Qu X; Tian L; Chen W; Kahan BD; Bennett CF
    Transplantation; 1998 Sep; 66(6):699-707. PubMed ID: 9771832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methoxyethyl modification of phosphorothioate ICAM-1 antisense oligonucleotides improves prevention of ischemic/reperfusion injury.
    Chen W; Bennett CF; Condon TP; Stecker K; Tian L; Kahan BD; Stepkowski SM
    Transplant Proc; 2001; 33(1-2):854. PubMed ID: 11267100
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of ICAM-1 gene expression by antisense 2',4'-BNA oligonucleotides.
    Obika S; Hemamayi R; Masuda T; Sugimoto T; Nakagawa S; Mayumi T; Imanishi T
    Nucleic Acids Res Suppl; 2001; (1):145-6. PubMed ID: 12836306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antisense intercellular adhesion molecule-1 (ICAM-1) oligodeoxyribonucleotide delivered during organ preservation inhibits posttransplant ICAM-1 expression and reduces primary lung isograft failure.
    Toda K; Kayano K; Karimova A; Naka Y; Fujita T; Minamoto K; Wang CY; Pinsky DJ
    Circ Res; 2000 Feb; 86(2):166-74. PubMed ID: 10666412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ICAM-1 and VCAM-1 antisense oligonucleotides attenuate in vivo leucocyte adherence and inflammation in rat inflammatory bowel disease.
    Rijcken E; Krieglstein CF; Anthoni C; Laukoetter MG; Mennigen R; Spiegel HU; Senninger N; Bennett CF; Schuermann G
    Gut; 2002 Oct; 51(4):529-35. PubMed ID: 12235075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the intercellular adhesion molecule-1(ICAM-1) in endotoxin-induced pneumonia evaluated using ICAM-1 antisense oligonucleotides, anti-ICAM-1 monoclonal antibodies, and ICAM-1 mutant mice.
    Kumasaka T; Quinlan WM; Doyle NA; Condon TP; Sligh J; Takei F; Beaudet Al; Bennett CF; Doerschuk CM
    J Clin Invest; 1996 May; 97(10):2362-9. PubMed ID: 8636417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of intercellular adhesion molecule-1 with antisense deoxynucleotides prolongs renal isograft survival in the rat.
    Dragun D; Lukitsch I; Tullius SG; Qun Y; Park JK; Schneider W; Luft FC; Haller H
    Kidney Int; 1998 Dec; 54(6):2113-22. PubMed ID: 9853277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of intercellular adhesion molecule-1 protein expression by antisense oligonucleotides is neuroprotective after transient middle cerebral artery occlusion in rat.
    Vemuganti R; Dempsey RJ; Bowen KK
    Stroke; 2004 Jan; 35(1):179-84. PubMed ID: 14657453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ICAM-1 antisense oligodesoxynucleotides prevent reperfusion injury and enhance immediate graft function in renal transplantation.
    Dragun D; Tullius SG; Park JK; Maasch C; Lukitsch I; Lippoldt A; Gross V; Luft FC; Haller H
    Kidney Int; 1998 Aug; 54(2):590-602. PubMed ID: 9690227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of FTY 720 and ICAM-1 antisense oligonucleotides for attenuating chronic renal damage secondary to ischemia-reperfusion injury.
    Troncoso P; Ortiz AM; Domínguez J; Kahan BD
    Transplant Proc; 2005 Dec; 37(10):4284-8. PubMed ID: 16387098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Involvement of ICAM-1/LFA-1 adhesion molecule set in rat orthotopic liver transplantation].
    Omura T
    Hokkaido Igaku Zasshi; 1994 Sep; 69(5):1220-31. PubMed ID: 7868060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization of ex vivo pressure mediated delivery of antisense oligodeoxynucleotides to ICAM-1 reduces reperfusion injury in rat cardiac allografts.
    Feeley BT; Poston RS; Park AK; Ennen MP; Hoyt EG; Vriens PW; Robbins RC
    Transplantation; 2000 Mar; 69(6):1067-74. PubMed ID: 10762209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delivery of intercellular adhesion molecule-1 antisense oligonucleotides using a topical hydrogel tissue sealant in a murine partial nephrectomy/ischemia model.
    Phull H; Lien YH; Salkini MW; Escobar C; Lai LW; Ramakumar S
    Urology; 2008 Sep; 72(3):690-5. PubMed ID: 18336877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blocking of heart allograft rejection by intercellular adhesion molecule-1 antisense oligonucleotides alone or in combination with other immunosuppressive modalities.
    Stepkowski SM; Tu Y; Condon TP; Bennett CF
    J Immunol; 1994 Dec; 153(11):5336-46. PubMed ID: 7963586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [ICAM-1 antisense therapy: a new treatment concept on Crohn disease? Placebo controlled study of ICAM-1 antisense oligonucleotide therapy in Crohn disease].
    Martignoni ME; Friess H
    Z Gastroenterol; 1999 Apr; 37(4):313-5. PubMed ID: 10378368
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy of ICAM-1 antisense oligonucleotide in pancreatic islet transplantation.
    Katz SM; Browne B; Phan T; Wang ME; Bennett CF; Stepkowski SM; Kahan BD
    Transplant Proc; 1995 Dec; 27(6):3214. PubMed ID: 8539920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.